Behavioral Depression Treatment for African American HIV-infected Substance Users

Completed · Not applicable

Conditions studied: Depression, Substance Use

In brief

The objective of the current study is to test a novel, behavioral approach to treat depressive symptoms and improve HIV medication adherence and subsequent physical health outcomes among African American HIV-infected substance users residing in inner-city Washington, DC. This treatment will serve as a compliment to standard residential and follow-up outpatient substance use treatment, with the goal of reducing depressive symptoms and improving HIV medication adherence, physical health, and substance use outcomes.

Key facts

Study ID

NCT01351454

Run by

University of North Carolina, Chapel Hill

People needed

61

Starts

2008-09-01

Expected to finish

2013-06-01

Last updated by the study team

2020-09-07

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• between 18 and 65 years of age
• HIV positive

You may not qualify if…

• psychosis
• the inability to give informed, voluntary, written consent to participate
• reading ability [below 3rd grade level on the WRAT]

Where it is running

• Salvation Army Harbor Light Treatment Center — Washington D.C., District of Columbia, United States
• University of Maryland — College Park, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.